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Abstract
Background:  The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited
neurodegenerative disorders characterized by accumulation of autofluorescent material in many
tissues, especially in neurons. Mutations in the CLN8 gene, encoding an endoplasmic reticulum (ER)
transmembrane protein of unknown function, underlie NCL phenotypes in humans and mice. The
human phenotype is characterized by epilepsy, progressive psychomotor deterioration and visual
loss, while motor neuron degeneration (mnd) mice with a Cln8 mutation show progressive motor
neuron dysfunction and retinal degeneration.
Results: We investigated spatial and temporal expression of Cln8 messenger ribonucleic acid
(mRNA) using in situ hybridization, reverse transcriptase polymerase chain reaction (RT-PCR) and
northern blotting. Cln8 is ubiquitously expressed at low levels in embryonic and adult tissues. In
prenatal embryos Cln8 is most prominently expressed in the developing gastrointestinal tract,
dorsal root ganglia (DRG) and brain. In postnatal brain the highest expression is in the cortex and
hippocampus. Expression of Cln8 mRNA in the central nervous system (CNS) was also analyzed in
the hippocampal electrical kindling model of epilepsy, in which Cln8 expression was rapidly up-
regulated in hippocampal pyramidal and granular neurons.
Conclusion: Expression of Cln8 in the developing and mature brain suggests roles for Cln8 in
maturation, differentiation and supporting the survival of different neuronal populations. The
relevance of Cln8 up-regulation in hippocampal neurons of kindled mice should be further explored.
Background
The neuronal ceroid lipofuscinoses (NCLs) comprise a
group of human neurodegenerative disorders (CLN1-
CLN8) characterized by epilepsy, visual failure,
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psychomotor deterioration and accumulation of autoflu-
orescent lipopigment in many tissues, especially in neu-
rons [1]. Six genes underlying human NCLs have been
identified and the proteins initially characterized
(reviewed in [2]). Naturally occurring mouse models exist
for CLN6 and CLN8 [3-5], while mouse models for CLN1,
CLN2 and CLN3 have been generated by gene targeting
[6-10].
The ubiquitously expressed CLN8 gene encodes a trans-
membrane protein which localizes to the ER and the ER-
Golgi intermediate compartment in non-neuronal cells
and to the ER in neuronal cells [4,11,12]. Mutations in
CLN8 result in two distinct NCL phenotypes in humans:
Northern epilepsy (Progressive epilepsy with mental retar-
dation, EPMR, OMIM 600143) described in Finnish
patients, and variant late infantile onset NCL in a subset
of Turkish patients [4,13]. EPMR is characterized by fre-
quent drug-resistant epileptic seizures with onset at 5–10
years of age, followed by progressive mental retardation
[14], while the Turkish patients show earlier onset and a
more rapid progression [15]. In EPMR, intracellular stor-
age material, including subunit c of the mitochonrdial
ATP synthase as the main protein component, is most
prominent in the CNS, especially in the third layer of the
isocortex and hippocampal regions CA2-4 [16]. In the cer-
ebral isocortex the pyramidal cells of the deeper parts of
lamina III are severely ballooned, and hippocampal
region CA2 shows neuronal loss and neuronophagy [16].
A frameshift mutation in mouse Cln8 that predicts a trun-
cated protein underlies the phenotype of the mnd mouse,
a naturally occuring NCL mouse model [4]. Contrary to
human patients, epilepsy is not a prominent feature in
mnd, which is characterized by progressive motor neuron
dysfunction and retinal degeneration [5,17,18]. The brain
appears to remain relatively intact [5,17,19]. Accumula-
tion of subunit c of the mitochondrial ATP synthase, neu-
rofilament redistribution in spinal motor neurons and
accumulation of ubiquitin deposits are characteristic for
mnd [20-22].
Here we characterized the spatial and temporal expression
of Cln8 mRNA in mice. Moreover, as epilepsy is the dom-
inant phenotype in human patients, we investigated the
CNS expression of Cln8 mRNA in the hippocampal elec-
trical kindling model of epilepsy in which repeated elec-
trical stimulations trigger a progressive intensification of
epileptiform responses, and kindled mice retain abnor-
mal excitability thereafter [23,24].
Results
The Cln8 gene is ubiquitously expressed in mouse tissues
The expression of the Cln8 gene in mouse tissues was first
analyzed by northern blot and real-time quantitative RT-
PCR analyses. In northern blot analysis one ~3 kilobase
(kb) Cln8 specific transcript was detected in all tissues
analyzed including a 14-day embryo (E14) (Fig. 1A). In
addition, one ~7 kb transcript was seen in all tissues
except testis and heart (Fig. 1A). In spleen, an additional
transcript of ~2 kb was detected (Fig. 1A). The ~7 kb and
~2 kb transcripts were notably weaker than the ~3 kb tran-
script. RT-PCR analysis covering the 867 bp open reading
frame of Cln8 resulted in a single fragment of the same
size in 12 different mouse tissues (data not shown), sug-
gesting that the different transcripts detected in the north-
ern analysis are not due to alternative splicing in the
coding region.
We then estimated the level of Cln8 expression using real-
time quantitative RT-PCR analysis. Cln8 showed highest
expression in liver, spleen, heart and skeletal muscle, 2.5,
2.2, 1.7 and 1.6 fold higher (respectively) than in the
brain (Fig. 1B). Expression was lowest in 11-day embryo
and adult kidney, lung and testis, 0.6, 0.9, 0.5 and 0.03
fold lower than in the brain (Fig. 1B). This indicates that
Cln8 expression levels in adult mouse tissues as well as in
whole mouse embryos are not dramatically different.
Cln8 is expressed throughout mouse development
The tissue expression of Cln8 during development and
brain maturation was characterized using radioactive
mRNA in situ hybridization analysis. For this purpose,
whole embryo sections from E13, E15.5 and E17 mice
and brain sections from postnatal (P) P0, P5, P10 and
adult mice were used and the expression of Cln8  was
quantitated by a computer based MCID image analysis
system.
In fresh-frozen E13 and E17 embryos the overall expres-
sion of Cln8 was weak. In E17 the most prominent expres-
sion was detected in the developing gastrointestinal tract
(Fig. 2A, 2B). In addition, there was high expression in the
DRG neurons (Fig. 2C, 2D). Some Cln8-specific signal was
also detected in the developing brain (Fig. 2E). The
expression of Cln8 in E13 was similar to that in E17 except
in the DRG neurons, where no signal was detected (data
not shown). In paraffin-embedded E15.5 embryos a Cln8-
specific signal was detected in the developing gastrointes-
tinal tract, adrenal glands and the developing brain, espe-
cially in the cortical plate (data not shown).
In postnatal mice (P0, P5, P10 and adult) Cln8 expression
was quantitated in the cortex, cerebellum and different
hippocampal regions. Expression at P0 was low but spe-
cific in hippocampal regions CA1, CA3 and the granular
cell layer of the dentate gyrus and in the cortex (Fig. 3). At
P5 and P10, the Cln8 expression increased in the hippoc-
ampal CA1 region (to 115% and 106% of P0) and espe-
cially in the CA3 region (to 139% of P0) (Fig. 3). In adult
brain the expression levels of Cln8 were lower than at P0,BMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
Page 3 of 11
(page number not for citation purposes)
Northern blot and RT-PCR analysis of Cln8 mRNA expression in mouse tissues Figure 1
Northern blot and RT-PCR analysis of Cln8 mRNA expression in mouse tissues A: Northern blot analysis of Cln8 
transcripts in mouse tissues. A β-actin probe was used as a control. Molecular weight marker in kb is shown on the left. B: 
Real-time quantitative RT-PCR analysis of Cln8 in mouse tissues. The expression of Cln8 in brain, given a value of 1, was used as 
a control. The expression of Cln8 in the other tissues is shown as a fold of the control.BMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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In situ hybridization analysis of Cln8 mRNA expression in mouse embryos Figure 2
In situ hybridization analysis of Cln8 mRNA expression in mouse embryos. In the E17 mouse embryo, developing 
gastrointestinal tract (A, B) and DRG (C, D), hybridized with Cln8 specific cRNA probe, are shown. Bright-field view of the 
cells is shown on the left (A, C) and dark-field detection of hybridization signals on the right (B,D). Optical density values of 
hybridization signals of Cln8 sense and antisense probes in E13 and E17 gut and brain tissues are shown in the diagram (E). 
Error bars represent standard error of the mean. s = sense, as = antisenseBMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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Differential distribution of Cln8 mRNA in brains of P0, P5, P10 and adult mouse Figure 3
Differential distribution of Cln8 mRNA in brains of P0, P5, P10 and adult mouse. Dark-field emulsion autoradio-
graphs from frontal sections, shown on the left, were analyzed by in situ hybridization analysis (A-D). Higher magnification in 
the hippocampal area CA3 is shown on the right. Bright-field views of the cells (a-d) and dark-field emulsion autoradiographs 
(a'-d') are shown. Optical density values of hybridization signals of Cln8 antisense probe are shown as bars in the diagram below 
(A = adult). Optical density values of hybridization signals of Cln8 sense probe are shown as a gray area behind the bars. In each 
brain region the optical density values at P0, P5 and P10 were compared to the optical density value of adult. Error bars repre-
sent standard error of the mean. Symbols *, ** and *** represent p < 0.05, 0.01 and 0.001, respectively. CX = cortex, DG = 
dentate gyrusBMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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P5 and P10 in every region analyzed (Fig. 3). When com-
pared with adults, a statistically significant difference in
Cln8 expression was detected in the cortex at P0, P5 and
P10 and in the CA3 region at P10 (Fig. 3). Expression of
Cln8 in adult cerebellum was 156% of expression in the
cortex (data not shown). In all maturation stages, the
expression of Cln8  was highest in hippocampal region
CA3 (Fig. 3).
Cln8 expression is strongly up-regulated in the 
hippocampal electrical kindling model of epilepsy
Epileptic seizures are a characteristic feature in human
patients with CLN8 mutations. We therefore analyzed, by
mRNA in situ hybridization analysis, possible changes in
Cln8 expression 2 h, 6 h and 24 h after kindling-induced
epileptic seizures. Animals were subjected to 40 rapid kin-
dling stimulations which lead to increased excitability in
mice at 4 weeks after the stimulation [25]. Each rapid kin-
dling stimulation induced relatively short focal (grade 0–
2) or long-lasting generalized (grade 4–5) seizures. The
mean duration of afterdischarges was 20 ± 3 s for focal sei-
zures and 76 ± 8 s for generalized seizures. All animals
experienced multiple (11 ± 2) grade 4–5 generalized
tonic-clonic seizures. The expression of Cln8 in the con-
trol, electrode implanted but non-stimulated mice (0 h;
Fig. 4) was essentially identical to that in wild-type adult
mouse brain (Fig. 3). After kindling stimulations Cln8 was
strongly up-regulated in the hippocampus, especially in
the CA3 region and most prominently in the granular cell
layer of the detate gyrus (Fig. 4). After 2 h, 6 h and 24 h
expression of Cln8 in CA3 was 92%, 114% and 134% of
that of controls, and in the granular cell layer of the den-
tate gyrus 128%, 225% and 286% of controls, respectively
(Fig. 4). When compared to controls, a statistically signif-
icant increase in Cln8 expression was detected in the cor-
tex after 6 h, and in the CA1 and CA3 regions, and the
granular cell layer of the dentate gyrus after 2 h, 6 h and
24 h (Fig. 4). All changes in Cln8 mRNA expression after
rapid kindling stimulations were bilateral with no differ-
ences between the sides.
Discussion
We analyzed the expression of the Cln8  gene during
mouse development and in the hippocampal kindling
model of epilepsy to gain understanding of the role of
CLN8 in the disease mechanisms underlying both human
and mouse NCLs. In northern blot analysis a Cln8 tran-
script of approximately 3 kb was detected in all tissues
studied. Two additional transcripts, approximately 2 kb
and 7 kb, were detected in several tissues. Thus, Cln8
expression resembles that of human CLN8, which is ubiq-
uitously expressed with transcripts of 1.4 kb, 3.4 kb and
7.5 kb [4]. The open reading frame of mouse Cln8 is 82%
identical with CLN8 and at the amino acid level the pro-
teins are 85% identical [4]. In both human and mouse
genes the RT-PCR analysis of the CLN8  open reading
frame resulted in a single fragment, suggesting that the dif-
ferent size transcripts seen in northern analysis are due to
alternative 3' untranslated regions as previously suggested
for the human CLN8 gene [4]. It is, however, also possible
that the CLN8/Cln8 genes have several transcription initi-
ation sites. Real-time quantitative RT-PCR analysis further
suggested that the expression levels of Cln8 are relatively
low in both adult and embryonic tissues, and showed that
expression levels in various tissues do not differ dramati-
cally. The remarkably low expression of Cln8  in testis
could reflect a high level of the control gene analyzed in
this tissue. Despite ubiquitous expression of the underly-
ing gene and accumulation of storage material in all tis-
sues, the most severe damage in EPMR patients and mnd
mice is in neuronal cells. This is also characteristic of other
NCLs, suggesting that NCL proteins may have a specific
function in neuronal cells distinct from the role in non-
neuronal cells, or that certain neuronal populations may
be more sensitive to the disturbed function of NCL
proteins.
In situ hybridization analysis of developing mice indicates
that Cln8 mRNA is expressed throughout development as
well as in the mature brain. The expression of Cln8 in
embryonic stages E13 and E17 was specific but low in
many tissues including brain, but remarkably high in the
developing gastrointestinal tract. This may indicate a role
for  Cln8  in the innervation of the developing gut. In
addition, in the E17 embryo Cln8 expression was high in
DRG neurons. These neurons determine the connections
between interneurons and motoneurons of the spinal
cord. Assuming a role for Cln8 in this process, its dis-
turbed function might result in defective connections in
DRG with consecutive dysfunction of motor neurons
resulting in progressive paralysis in the mnd mouse model
[5,17]. The expression of Cln8 in postnatal mouse brain
was highest at developmental stages P5 and P10, espe-
cially in hippocampal region CA3. The brain expression
was clearly lower in adult mice than at P0, P5 and P10,
suggesting a role for Cln8 in brain maturation. This early
postnatal period is characterized by a rapid increase in the
number of synapses, as well as maturation of oli-
godendrocytes, the myelin-forming cells in the CNS [26].
Two other NCL proteins, Ppt1 and Cln3, have been local-
ized to synaptic areas of neurons [27,28] suggesting the
importance of these NCL proteins for synaptic functions.
However, detailed study of the function of Cln8 in the
CNS and different brain cells is currently hampered by the
lack of a specific antibody detecting endogenous Cln8.
Very low levels of Cln8 mRNA were also detected in devel-
oping and adult motoneurons and retina (data not
shown). However, the Cln8 transcript levels in these sam-
ples were virtually indistinguishable from the respective
sense controls.BMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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Distribution of Cln8 mRNA in brains of hippocampal kindling induced epileptic mice Figure 4
Distribution of Cln8 mRNA in brains of hippocampal kindling induced epileptic mice. Frontal mouse brain sections 
were analyzed 2 h, 6 h and 24 h after kindling induced epileptic seizures by in situ hybridization. Mice with electrodes implanted 
but without electrical stimulations were used as controls (0 h). Dark-field emulsion autoradiographs of hippocampal Cln8 
expression in kindling-induced mice 0 h and 24 h after kindling are shown. Optical density values of hybridization signals of Cln8 
antisense probe are shown as bars in the diagram. Optical density values of hybridization signals of Cln8 sense probe are shown 
as a gray area behind the bars. In each brain region the optical density values 2 h, 6 h and 24 h after kidling-induced seizures 
were compared to controls (0 h). Error bars represent standard error of the mean. Symbols *, ** and *** represent p < 0.05, 
0.01 and 0.001, respectively. DG = dentate gyrusBMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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The expression of several other NCL genes in mouse and/
or rat has been characterized. In addition to Cln8, Cln1
and Cln5 also show developmental regulation, whereas
the expression of two other NCL genes, cathepsin D under-
lying a naturally occuring sheep NCL model and Cln2
underlying a human late infantile-onset NCL form, is rel-
atively constant in the rat brain during development [29-
32]. Mouse Cln3 is expressed in adult mice throughout the
brain, and in the hippocampus the most prominent
expression is detected in the granular cell layer of the den-
tate gyrus and pyramidal cells [28]. In addition, human
CLN1 and CLN5 genes are expressed at the beginning of
neurogenesis in embryonic human brains [33]. This
expression increases as brain development proceeds.
Expression of NCL genes, including Cln8, in the develop-
ing and mature brain indicates that NCL proteins may
have roles not only in supporting the survival of neurons
but also in the maturation and differentiation of different
neuronal populations during development. Defects in
maturation processes could potentially lead to neuronal
degeneration and loss of neurons.
In the kindling model of experimental epilepsy a rapid
up-regulation of Cln8  expression was detected in the
brain, especially in hippocampal regions CA3 and the
granular cell layer of the dentate gyrus. The expression of
Cln8  increased at every time point measured, and was
highest 24 h after kindling. Whether single or focal
seizures alone are sufficient to induce Cln8  expression
requires further investigation. While only Cln8 expression
has been investigated in the kindling model, expression of
cathepsin D and the Cln1  encoded palmitoyl protein
thioesterase 1 (Ppt1) protein has been studied using kai-
nic acid-induced seizures in rats as a model. Both show
increased expression in this model, cathepsin D in the hip-
pocampus, limbic cortex and temporo-parieto-occipital
neocortex [34] and the Ppt1 protein most prominently in
pyramidal cells of hippocampal regions CA1 and CA3
[35]. Although different forms of NCLs are genetically het-
erogenous, they share a common hippocampal pathol-
ogy, which is distinct from lesions caused by anoxic-
ischemic events and is instead suggested to be a conse-
quence of primary metabolic defects [36]. Increased
plasma glutamate levels, decreased glutamate uptake,
descreased glutamate transporters as well as changes in
ionotropic glutamate receptors has been described in mnd
mice [37,38]. Also, prominent loss of GABAergic
interneurons in mnd  as well as in the Cln1  and  Cln3
knock-out mice has been reported [39-41]. Alterations in
both glutamatergic and GABAergic neurotransmission
may both contribute to chronic excitotoxicity, hypothe-
sized to underlie the cellular dysfunction and brain
pathology in NCL disorders [42].
Conclusion
The Cln8 gene is widely expressed in embryonic and adult
mouse tissues. In line with this, and comparable with
other NCL disorders, accumulation of storage deposits in
CLN8-associated disorders occurs in all tissues. However,
as the most striking accumulation and cellular dysfunc-
tion is limited to neurons, it is likely that CLN8/Cln8 is
involved in a neuron-specific biochemical pathway or that
neuronal cells are more sensitive to accumulating material
or lack compensatory pathways.
The Cln8 gene is expressed throughout brain development
and also in mature brain, suggesting a role for Cln8 in
maturation and differentiation of neurons and in support-
ing the survival of neurons. The expression of Cln8
showed regional differences, suggesting a specific func-
tion for Cln8 in specific neuronal populations. The rele-
vance of Cln8 up-regulation in hippocampal neurons of
kindled mice needs to be studied further.
Methods
Northern blot analysis
FirstChoice™ Northern Blot Mouse Blot I (Ambion, Aus-
tin, TX, USA) was used to analyze the distribution of Cln8
expression in various tissues. An 872 base pair (bp) deox-
yribonucleic acid (DNA) fragment including a Cln8 open
reading frame of 867 bp, digested from the SvPoly-Cln8
expression vector with restriction enzyme BamHI, was
used as a probe. The hybridization was performed accord-
ing to the manufacturer's instructions with Ultra sensitive
Hybridization buffer (Ambion), and salmon sperm DNA
and Cot-1 DNA for blocking.
Real-time quantitative RT-PCR analysis of Cln8
Real-time quantitative RT-PCR analysis of Cln8 was per-
formed in an ABI PRISM®  7000 SDS thermal cycler
(Applied Biosystems, Foster City, CA, USA) using 5 µl of
each tissue from Mouse Multiple Tissue cDNA (MTC™)
Panel II (BD Biosciences) as template. Each 25 µl reaction
contained 300 nM of reverse primer 5'-CCACTGGTT-
GGCCTTCCA-3' and 900 nM of forward primer 5'-
GCCCTTCACCTGCATTTCC-3' as well as 200 nM of Cln8
specific probe 6FAM-TGACCACCCAGCCTTCAGGAG-
CAT-TAMRA in TaqMan®  Universal PCR Master Mix
(Applied Biosystems). The primers were optimized for
analysis and the PCR fragment of 76 bp covered the region
from 510 to 585 bp of the Cln8 open reading frame (Gen-
Bank sequence accession no AF125307). The Cln8 specific
probe included a reporter dye 6-carboxyfluorescein (FAM)
and a quencher dye 6-carboxy-tetramethyl-rhodamine
(TAMRA). Endogenous control reactions were performed
using Assays-on-Demand Mm00446973_m1 TATA-box
binding protein amplification according to the manufac-
turer's instructions (Applied Biosystems). Each reaction
was performed in triplicate. Standard complementaryBMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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DNA (cDNA) solutions, generated from C57/BL mice cor-
tex mRNA, and standard curve method were used (User
Bulletin #2: ABI PRISM(R) 7700 Sequence Detection Sys-
tem. P/N 4303859B (2001) Applied Biosystems. 36 s.).
Statistical analyses were performed using Microsoft Excel.
The DNA fragment covering the whole open reading




Paraffin and cryosections of NMRI or C57/BL mice were
prepared and analyzed by mRNA in situ hybridization as
previously described [43-45] with slight modifications.
The isolated tissues from postnatal wild-type and kindling
mice were fresh-frozen and sectioned. Embryos were
either fixed in 4% paraformaldehyde and embedded in
paraffin or fresh-frozen and sectioned. For all serial sec-
tions of 8–14 µm, a single 35S-labeled 370 bp Cln8 specific
complementary RNA (cRNA) probe (from bp 29 to 398;
GeneBank AF125307) was used. For the generation of the
antisense and control sense cRNAs, the vector (pBlue-
script vector; Stratagene, La Jolla, CA, USA) containing the
PCR-amplified Cln8 fragment was linearized and used as
a template for RNA polymerases T3 and T7, respectively,
using  α-35S-labeled UTP (Amersham Biosciences, Upp-
sala, Sweden).
The paraffin sections were treated as cryosections, after
first being deparaffinized in xylene and rehydrated in a
descending ethanol series. All the slides were fixed in 4%
paraformaldehyde, rinsed twice in phosphate-buffered
saline and treated with proteinase K (20 µg/ml for paraffin
sections, 1 µg/ml for cryosections). Next, the slides were
postfixed in 4% paraformaldehyde, and the cryosections
rinsed in 50% deionized formamide in 2 × standard
sodium citrate (SSC). After being washed in distilled
water, all slides were acetylated for 10 minutes with
0.25% acetic anhydride in 0.1 M triethanolamine. The
paraffin sections were then dehydrated in an ascending
ethanol series, while the cryosections were rinsed again
with 50% formamide in 2 × SSC. Prehybridization for 1 h
was subsequently performed at +52°C with hybridization
buffer containing 60% formamide, 10% dextran sulphate,
1 × Denhardt's solution, 0.5 mg/ml yeast transfer RNA
(tRNA), and 100 mM dithiothreitol. After prehybridiza-
tion, cRNA probes were added to the hybridization buffer
at a concentration of 35 000 cpm/µl, and hybridization
was carried out overnight at +52°C in a chamber humidi-
fied with 60% formamide and 5 × SSC.
After hybridization the sections were first washed in 5 ×
SSC, 10 mM dithiothreitol at +50°C for 30 minutes, fol-
lowed by 30 minutes in 50% formamide, 2 × SSC, 30 mM
dithiothreitol at +65°C, and 3 × 10 minutes in NTE-buffer
(0.5 M NaCl, 10 mM Tris-HCl, pH 8.0, 5 mM EDTA) at
+37°C. Next, the slides were treated with RNase A (20 µg/
ml) in NTE-buffer at +37°C for 30 min and washed for 15
min in NTE-buffer at +37°C. Washing with 50% forma-
mide, 2 × SSC, 30 mM dithiothreitol was then repeated,
after which the sections were washed in 2 × SSC and 0.1 ×
SSC, each for 15 min at +37°C. The slides were dehy-
drated at room temperature with ethanol containing 0.3
M ammonium acetate, air-dried, and exposed to BioMax
MR Film (Kodak) together with 14C radioactive standards
(Amersham Biosciences) for 5 days. Finally, the sections
were dipped in NTB-2 emulsion (Kodak), developed after
3 to 4 weeks using D-19 developer (Kodak), fixed with
Kodak Unifix, counterstained with hematoxylin (Shan-
don Inc./Thermoshandon, Pittsburgh, PA, USA), and
mounted with Permount (Fisher Scientific International
Inc., Hampton, NH, USA). Mice were bred in the Viikki
Laboratory Animal Center, University of Helsinki. The
experiments were conducted according to the "European
Convention for the Protection of Vertebrate Animals used
for Experimental and other Scientific purposes" with the
approval of the institutional ethics committee.
Rapid kindling procedure
Adult male C57/BL mice weighing 22–25 g (n = 16) were
anaesthetized with sodium pentobarbital (60 mg/kg i.p.),
and bipolar stainless steel electrodes (Plastics One) were
implanted in the left ventral hippocampus using a Kopf
stereotaxic frame as previously described [46]. One week
later, the mice were electrically stimulated with forty
threshold stimulations with 5 min intervals (10 Hz fre-
quency, 1 ms square-wave pulses for 10 s). The
electroencephalogram was continuously recorded during
the whole rapid kindling procedure using the MacLab/4e
system (ADInstruments). To determine the threshold, cur-
rent intensity was increased stepwise (10 µA increments,
starting from 10 µA) every 5 min until focal epileptiform
activity (afterdischarge) of at least 5 s duration was elic-
ited. Rapid kindling stimulations were then given on the
same day. Behavioral convulsions were scored according
to a modification [25] of the scale of Racine [47]: grade 0,
arrest, normal behavior; grade 1, facial twitches; grade 2,
chewing and nodding; grade 3, forelimb clonus; grade 4,
rearing, body jerks, tail upholding; and grade 5, imbal-
ance, hind-limb clonus and vocalization. At 2, 6 and 24 h
after the last stimulus-evoked seizure, animals were
decapitated (four animals in each group) and brains were
processed for in situ hybridization. Four non-stimulated,
electrode-implanted mice served as controls and were
killed together with the experimental animals from differ-
ent groups. The correct localization of the electrode was
controlled for each animal in the coronal sections of the
brain used for in situ hybridization. All experimental pro-BMC Neuroscience 2005, 6:27 http://www.biomedcentral.com/1471-2202/6/27
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cedures were approved by the Research Ethics Committee
at the Medical Faculty of the University of Lund.
Quantitative and statistical analysis
Quantification of radioactive in situ hybridization films
was done by digitizing the film images with a computer-
based MCID image analysis system (Imaging Research).
Gray levels from 14C radioactive standards were used in a
third-degree polynomial calibration to obtain equivalent
values of tissue radioactivity (nCi/g) for different brain
regions. Measurements for each structure were carried out
in several sections per animal. Since there were no signif-
icant differences between the two sides, values were
pooled to obtain the mean value for each animal and
brain region. Data from four control and four experimen-
tal animals for every probe and time point were used for
analysis. Statistical analysis was performed using Stu-
dent's t-tests. In the figures, the densities of hybridization
signals of sense and antisense probes are shown sepa-
rately. Sense values were not subtracted from antisense
values because of different probes used. Error bars repre-
sent standard error of the mean; symbols *, ** and ***
represent p < 0.05, 0.01 and 0.001, respectively.
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